Stacy J Keding

US Patent:

7854934, Dec 21, 2010

Filed:

Jul 31, 2002

Appl. No.:

10/209618

Inventors:

Samuel J. Danishefsky - Englewood NJ, US
Don M. Coltart - New York NY, US
Stacy J. Keding - New York NY, US
Kaustav Biswas - Thousand Oaks CA, US
Philip O. Livingston - New York NY, US
Jennifer R. Allen - Indianapolis IN, US
Lawrence Williams - Edison NJ, US

Assignee:

Sloan-Kettering Institute For Cancer Research - New York NY

International Classification:

A01N 43/04
A61K 39/385
A61K 31/70
A61K 31/715

US Classification:

4241931, 514 8, 514 23, 514 25, 514 42, 514 53, 514 54, 514 62, 530322, 5361231

Abstract:

The present invention provides novel glycosides and glycoconjugates, glycoamino acids, and methods for the synthesis thereof. In another aspect, the present invention provides novel clustered glycopeptides and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, preferably for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need, an effective amount of any of the inventive glycopeptides as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier.

US Patent:

8168659, May 1, 2012

Filed:

Oct 22, 2007

Appl. No.:

12/441570

Inventors:

David Scott Coffey - Fishers IN, US
Jingdan Hu - Carmel IN, US
Stacy Jo Keding - Zionsville IN, US
John Mehnert Schaus - Zionsville IN, US
David Edward Tupper - Basingstoke, GB

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K 31/4439
C07D 401/12

US Classification:

514343, 5462784

Abstract:

Compounds and pharmaceutical compositions comprising compounds of the Formula.

US Patent:

20040208884, Oct 21, 2004

Filed:

Dec 3, 2003

Appl. No.:

10/728041

Inventors:

Samuel Danishefsky - Englewood NJ, US
Stacy Keding - New York NY, US

International Classification:

A61K039/00
C07K014/47

US Classification:

424/185100, 530/404000

Abstract:

The present invention provides novel clustered multi-antigenic constructs having the structure: and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, preferably for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need, an effective amount of any of the inventive constructs as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier.

US Patent:

20180079729, Mar 22, 2018

Filed:

Apr 13, 2016

Appl. No.:

15/561163

Inventors:

- Indianapolis IN, US
Erik James Hembre - Indianapolis IN, US
Nicholas Allan Honigschmidt - Lakeville MN, US
Maria Angeles Martinez-Grau - Madrid, ES
Gema Ruano Plaza - Madrid, ES
Almudena Rubio - Carmel IN, US
Stacy Jo Keding - Brownsburg IN, US
Daryl Lynn Smith - Fishers IN, US

International Classification:

C07D 239/42
C07D 401/12
C07D 417/14

Abstract:

The present invention provides novel GOAT inhibitors and their salts and pharmaceutical compositions thereof.